Prior work has demonstrated that MM cells reduce the number of viable osteocytes in both patients and animal models [10, 23, 24], while also stimulating sclerostin production by osteocytes, though this has only been reported in preclinical models [10, 24]. Here, SOST is linked to Miyoshi myopathy.